Pfizer
Sort by
2 items
Filter
Items per page
-
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
The agency greenlighted the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.CNBC - Business -
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S.NBC News - Top stories